Table 4.
Opioidb | Conversion Factor |
---|---|
Codeine | 0.15 |
Fentanyl transdermal, μg/h | 2.4 |
Hydrocodone | 1 |
Hydromorphone | 4 |
Methadone, mg/d | |
1–20 | 4 |
21–40 | 8 |
41–60 | 10 |
≥61–80 | 12 |
Morphine | 1 |
Oxycodone | 1.5 |
Oxymorphone | 3 |
Tapentadolc | 0.4 |
Adapted from Von Korff M, Saunders K, Ray GT, et al. Clin J Pain. 2008;24:521–527, and Interagency Guideline on Prescribing Opioids for Pain. Washington State Agency Medical Directors’ Group. http://www.agencymeddirectors.wa.gov/Files/2015AMDGOpioidGuideline.pdf. Accessed February 19, 2016.
All doses are in mg/d except for fentanyl, which is μg/h. Multiply the daily dosage for each opioid by the conversion factor to determine the dose in morphine milligram equivalents (MME). For example, tablets containing hydrocodone, 5 mg, and acetaminophen, 300 mg, taken 4 times a day would contain a total of 20 mg of hydrocodone daily, equivalent to 20 MME daily; extended-release tablets containing oxycodone, 10 mg, and taken twice a day would contain a total of 20 mg of oxycodone daily, equivalent to 30 MME daily.
Tapentadol is a μ-receptor agonist and norepinephrine reuptake inhibitor. Morphine milligram equivalents are based on degree of μ-receptor agonist activity, but it is unknown if this drug is associated with overdose in the same dose-dependent manner as observed with medications that are solely μ-receptor agonists.